Lantern Pharma Inc. (LTRN) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to our first quarter 2025 earnings call. As a reminder, this call is being recorded and all attendees are in a listen-only mode. We will open the call for questions and answers after our management's presentation. A webcast replay of today's conference call will be available on our website at lanternpharma.com shortly after the call. We issued a press release before the market opened today, summarizing our financial results and progress across the company for the first quarter ended March 31st, 2025. A copy of this release is available through our website at lanternpharma.com. where you will also find a link to the slides management will be referencing on today's call. We would like to remind everyone that remarks about future expectations, performance, estimates, and prospects constitute forward-looking statements for purposes of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Lantern pharma cautions that these forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated. A number of factors could cause actual results to differ materially from those indicated by forward looking statements, including results of clinical trials and the impact of competition. Additional information concerning factors that could cause actual results to differ materially from those in the forward looking statements can be found in our annual report on form 10 K for the year ended December 31 2024. Which is on file with the SEC and available on our website forward looking statements made on this conference call are as of today may 15 2025. And Lantern Pharma does not intend to update any of these forward-looking statements to reflect events from circum...